rs1553403917
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_001378454.1(ALMS1):c.4645dupA(p.Arg1549LysfsTer10) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (no stars). Synonymous variant affecting the same amino acid position (i.e. R1549R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001378454.1 frameshift
Scores
Clinical Significance
Conservation
Publications
- Alstrom syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, G2P, Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 39
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Alstrom syndrome Pathogenic:1
This homozygous frameshift variation NM_015120.1:c.4648dup;p.(Arg1550Lysfs*10), identified in a patient with Alstrom Syndrome (OMIM# 203800), lies in exon 8 of the ALMS1 gene. A vast majority of reported ALMS1 mutations associated to the syndrome are localized in exon 8 (the largest among the 23 exons of the gene) and are almost all stop codon or frameshift variations resulting in the early termination of the protein. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at